Detection of circulating tumor cells in peripheral blood of colorectal cancer patients without distant organ metastases

[11] Ward E(2008)Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer J. Clin. Oncol. 26 3213-3221

[12] Brawley OW(2007)Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma World J. Surg. 31 2329-2334

[13] Guller U(2000)Guanylyl cyclases and signaling by cyclic GMP Pharmacol. Rev. 52 375-414

[14] Zajac P(2003)Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease Oncol. Rep. 10 217-222

[15] Schnider A(2005)Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract Hum. Pathol. 36 170-179

[16] Bosch B(1996)Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues Proc. Natl. Acad. Sci. U. S. A. 93 14827-14832

[17] Vorburger S(2004)Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study Dis. Colon Rectum 47 679-686

[18] Zuber M(2001)Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent Gastroenterology 121 1191-1202

[19] Spagnoli GC(2005)Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer Expert. Rev. Mol. Diagn. 5 701-713

[20] Oertli D(2006)A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer Clin. Cancer Res. 12 4545-4552

[11] Ward E(2008)Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer J. Clin. Oncol. 26 3213-3221

[12] Brawley OW(2007)Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma World J. Surg. 31 2329-2334

[13] Guller U(2000)Guanylyl cyclases and signaling by cyclic GMP Pharmacol. Rev. 52 375-414

[14] Zajac P(2003)Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease Oncol. Rep. 10 217-222

[15] Schnider A(2005)Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract Hum. Pathol. 36 170-179

[16] Bosch B(1996)Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues Proc. Natl. Acad. Sci. U. S. A. 93 14827-14832

[17] Vorburger S(2004)Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study Dis. Colon Rectum 47 679-686

[18] Zuber M(2001)Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent Gastroenterology 121 1191-1202

[19] Spagnoli GC(2005)Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer Expert. Rev. Mol. Diagn. 5 701-713

[20] Oertli D(2006)A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer Clin. Cancer Res. 12 4545-4552